×


 x 

Shopping cart
Augusto . Ed(S): Villanueva - Resistance to Molecular Therapies for Hepatocellular Carcinoma - 9783319561967 - V9783319561967
Stock image for illustration purposes only - book cover, edition or condition may vary.

Resistance to Molecular Therapies for Hepatocellular Carcinoma

€ 193.74
FREE Delivery in Ireland
Description for Resistance to Molecular Therapies for Hepatocellular Carcinoma Hardback. Editor(s): Villanueva, Augusto. Series: Resistance to Targeted Anti-Cancer Therapeutics. Num Pages: 270 pages, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational. .

This volume evaluates the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold standard to define radiological resistance; describes the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment; determines the role of the cancer stem cell phenotype in resistance; reviews the experimental models to study resistance; and addresses new approaches to overcome resistance to sorafenib, using successful examples from other malignancies. 

    Product Details

    Format
    Hardback
    Publication date
    2017
    Publisher
    Springer International Publishing AG Switzerland
    Number of pages
    270
    Condition
    New
    Series
    Resistance to Targeted Anti-Cancer Therapeutics
    Number of Pages
    147
    Place of Publication
    Cham, Switzerland
    ISBN
    9783319561967
    SKU
    V9783319561967
    Shipping Time
    Usually ships in 15 to 20 working days
    Ref
    99-15

    About Augusto . Ed(S): Villanueva
    Augusto Villanueva, MD, PhD, is Assistant Professor, Division of Liver Diseases, Liver Cancer Program, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine, NYC.

    Reviews for Resistance to Molecular Therapies for Hepatocellular Carcinoma

    Goodreads reviews for Resistance to Molecular Therapies for Hepatocellular Carcinoma


    Subscribe to our newsletter

    News on special offers, signed editions & more!